Cobar, Freya Venventia .
HRN: 21-22-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/30/2022
06/05/2022
IVT
320mg
Q6
PCAP-C, (+) Seizure
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes